SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (2737)1/31/2001 11:58:42 AM
From: JOEBT1  Read Replies (1) | Respond to of 52153
 
Peter--When I spoke to IR at LEXG they said they have brought a lawsuit against DGEN because they violated LEXG's patents on their mouse knockout technology. I've recently bought TELK and LEXG but PRCS is the best bet IMO when it dips a little on their upcoming secondary offering. Do you have an opinion on these three stocks?
Joe



To: Biomaven who wrote (2737)1/31/2001 12:06:23 PM
From: IRWIN JAMES FRANKEL  Read Replies (1) | Respond to of 52153
 
LEXG

I bought it at 12.5 and also sold puts at 12.5. Looked under appreciated to me.

ij



To: Biomaven who wrote (2737)1/31/2001 7:37:49 PM
From: Scott H. Davis  Respond to of 52153
 
RE the Genomics - FYI, rather negative report. thestreet.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News